Brain Tumour Conference 2024: Programme

Brain Tumour Conference 2024 hero image

Brain Tumour Conference 2024

Tuesday 24 September 2024

11:00 - 11:15


11:15 - 12:15

Keynote lecture: Arnold Kriegstein, University of California, San Francisco

Neural stem cells in human brain development and glioblastoma

12:15 - 12:30

Lightning talks

12:30 - 13:45 Lunch, network and exhibition
13:45 - 15:30

Session 1: Brain metastasis

Chair and speaker: Erica Sloan, Monash University

Speaker: Leanne Li, The Francis Crick Institute

Cancer cell intrinsic electrical activity drives small cell lung cancer progression

Speaker: Manuel Valiente, Spanish National Cancer Research Center (CNiO)

Strategies to challenge brain metastasis lethality and to improve QoL in mice and human

15:30 - 16:00 Networking break
16:00 - 17:45

Session 2: Spatial sequencing

Chair and speaker: Omer bayraktar, Wellcome Sanger Institute

Mapping the rules of glioblastoma with integrated single cell and spatial genomics

Speaker: Dieter Henrik Heiland, Friedrich-Alexander University

Transitioning spatially resolved multi-omics into clinical applications through advanced machine learning

Speaker: Itay Tirosh, Weizmann Institute of Science

Spatial analysis of gliomas and their invasion

17:45 - 19:30 Networking and poster session

Wednesday 25 September 2024

9:00 - 10:45

Session 3: 3D genomes

Chair and speaker: Claudia Kleinman, McGill University

Speaker: Wendy Bickmore, University of Edinburgh

Nuclear organisation, gene regulation and ecDNAs

Speaker: Bing Ren, University of California, San Diego

Single cell epigenome analysis of brain cell diversity and tumor heterogeneity

10:45 - 11:15 Networking break
11:15 - 13:00

Session 4: Clinical trials

Chair and speaker: Darren Hargrave, University College London/Great Ormond Stree Hospital

Speaker: Juanita Lopez, The Royal Marsden/The Institute of Cancer Research

Disruptive trial design for genomically complex brain tumours

Speaker: Nader Sanai, Barrow Neurological Institute

Pharmacokinetic/pharmacodynamic-driven clinical trials for brain tumours

13:00 - 14:30 Lunch and networking, with industry talk
14:30 - 14:45 Lightning talks
14:45 - 16:30

Session 5: Artificial intelligence/machine learning

Chair and speaker: Bissan Al-Lazikani, MD Anderson Cancer Center

Speaker: Steven Nederer, Imperial College London & The Alan Turing Institute

The Virtual Patient, lessons from cardiac digital Ttins

Speaker: Richard Gilbertson, Cancer Research UK Cambridge Institue & University of Cambridge

16:30 - 18:30 Networking and poster session
18:30 - 23:00 Conference dinner

Thursday 26 September 2024

9:00 - 10:05

Keynote lecture: Karen Vousden, The Francis Crick Institute

Diet, metabolism and cancer progression

10:05 - 10:15 Patient representative introduction
10:15 - 10:55 Panel discussion – why aren't we curing brain tumours?
10:55 - 11:30 Networking and refreshments
11:30 - 13:15

Session 6: Brain tumour metabolism

Chair and speaker: Craig Thompson, Memorial Sloan Kettering Cancer Center

Targeting the vulnerabilities of IDH mutant gliomas

Speaker: Christiane Opitz, German Cancer Research Center (DKFZ)

Brain tumour metabolism

Speaker: Sriram Venneti, University of Michigan

Advancing oncometabolism in brain tumors

13:15 - 14:15 Lunch and networking
14:15 - 16:00

Session 7: Model organisms and the tumour microenvironment

Chair and speaker: Simona Parrinello, University College London

Speaker: Manav Pathania, University of Cambridge

A compendium of syngeneic, transplantable paediatric high-grade glioma models reveals subtype-specific therapeutic vulnerabilities

Speaker: Anne Rios, Princess Máxima Center

Organoid human cancer immunity models in motion

16:00 - 16:15 Closing remarks


The conference programme is subject to change.